Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03883633 · ClinicalTrials.gov registry record

Reversal of Cognitive Decline (ReCODE) Study

A clinical trial, sponsored by QuesGen Systems.

Completed
Registry status
30
Enrollment target

NCT03883633 is a clinical trial that has completed, run by QuesGen Systems. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03883633 has completed, sponsored by QuesGen Systems.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

Prospective study on patients enrolled in the ReCODE treatment protocol

Interventions

  • BEHAVIORAL ReCODE Protocol

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-06-30
Est. Completion 2020-12-31

Sponsor

QuesGen Systems

2 total trials

What the Registry Record Tells You About NCT03883633

The ClinicalTrials.gov registry entry for NCT03883633 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QuesGen Systems, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ReCODE Protocol is the first listed.

NCT03883633 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03883633 about?

NCT03883633 is a clinical study titled "Reversal of Cognitive Decline (ReCODE) Study". Prospective study on patients enrolled in the ReCODE treatment protocol

What is the current status of trial NCT03883633?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-06-30. Estimated completion is 2020-12-31.

What interventions are being tested in trial NCT03883633?

The interventions under investigation include: ReCODE Protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT03883633?

This trial is sponsored by QuesGen Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.